Secondary Logo

Journal Logo

November-December 2006 - Volume 29 - Issue 6
pp: 575-687





The Antitumor Activity of IL-27 and IL-2: Synergistic Enhancement of Immune-Responsiveness and Induction of the Complete Regression of Disseminated Neuroblastoma Metastases in the Liver and Bone Marrow

Wigginton, Jon; Hixon, Julie A.; Stauffer, Jimmy K.; More

Journal of Immunotherapy. 29(6):642, November-December 2006.


Vaccination With Multiple Melanoma Peptides Stimulates Promiscuous and Synergistic Helper T Cell Response: A Phase I/II Trial in Advanced Melanoma

Czarkowski, Andrea R.; Olson, Walter C.; Chianese-Bullock, Kimberly A.; More

Journal of Immunotherapy. 29(6):646, November-December 2006.

Survival in Successive Phase II Trials of Patient-Specific Vaccines From Autologous Tumor Cell Lines, With or Without Dendritic Cells, in Patients With Metastatic Melanoma

Dillman, Robert O.; Selvan, Senthamil R.; Schiltz, Patric M.; More

Journal of Immunotherapy. 29(6):647, November-December 2006.

Development of Live-Attenuated L. Monocytogenes Platforms for Immunotherapy in Patients With Carcinoma

Dubensky, Thomas W.; Brockstedt, Dirk G.; Leong, Meredith L.; More

Journal of Immunotherapy. 29(6):647, November-December 2006.

Preliminary Results of a Pilot-Phase I Clinical Trial for Lung Cancer Patients Using an Autologous Tumor Cell Vaccine Following Preparative Chemotherapy and Reconstitution With Autologous PBMC

Rüttinger, Dominik; Winter, Hauke; van den Engel, Natasja K.; More

Journal of Immunotherapy. 29(6):655, November-December 2006.